Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W., Fedorov, O., Morse, E., Keates, T., Hickman, T., Felletar, I.... (2010) Selective inhibition of BET bromodomains. Nature, 468(7327), 1067-1073. DOI: 10.1038/nature09504  

Puissant, A., Frumm, S., Alexe, G., Bassil, C., Qi, J., Chanthery, Y., Nekritz, E., Zeid, R., Gustafson, W., Greninger, P.... (2013) Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition. Cancer Discovery, 3(3), 308-323. DOI: 10.1158/2159-8290.CD-12-0418  

Lin, C., Lovén, J., Rahl, P., Paranal, R., Burge, C., Bradner, J., Lee, T., & Young, R. (2012) Transcriptional Amplification in Tumor Cells with Elevated c-Myc. Cell, 151(1), 56-67. DOI: 10.1016/j.cell.2012.08.026  

Mertz, J., Conery, A., Bryant, B., Sandy, P., Balasubramanian, S., Mele, D., Bergeron, L., & Sims, R. (2011) Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proceedings of the National Academy of Sciences, 108(40), 16669-16674. DOI: 10.1073/pnas.1108190108  

Schnepp, R., & Maris, J. (2013) Targeting MYCN: A Good BET for Improving Neuroblastoma Therapy?. Cancer Discovery, 3(3), 255-257. DOI: 10.1158/2159-8290.CD-13-0018  

Garon, E., Finn, R., Hosmer, W., Dering, J., Ginther, C., Adhami, S., Kamranpour, N., Pitts, S., Desai, A., Elashoff, D.... (2010) Identification of Common Predictive Markers of In vitro Response to the Mek Inhibitor Selumetinib (AZD6244; ARRY-142886) in Human Breast Cancer and Non-Small Cell Lung Cancer Cell Lines. Molecular Cancer Therapeutics, 9(7), 1985-1994. DOI: 10.1158/1535-7163.MCT-10-0037  

Sarli, V., & Giannis, A. (2008) Targeting the Kinesin Spindle Protein: Basic Principles and Clinical Implications. Clinical Cancer Research, 14(23), 7583-7587. DOI: 10.1158/1078-0432.CCR-08-0120  

Tunquist, B., Woessner, R., & Walker, D. (2010) Mcl-1 Stability Determines Mitotic Cell Fate of Human Multiple Myeloma Tumor Cells Treated with the Kinesin Spindle Protein Inhibitor ARRY-520. Molecular Cancer Therapeutics, 9(7), 2046-2056. DOI: 10.1158/1535-7163.MCT-10-0033  

Jänne, P., Shaw, A., Pereira, J., Jeannin, G., Vansteenkiste, J., Barrios, C., Franke, F., Grinsted, L., Zazulina, V., Smith, P.... (2012) Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study. The Lancet Oncology. DOI: 10.1016/S1470-2045(12)70489-8  

Sun, J., Liu, Q., Wang, J., Ahluwalia, D., Ferraro, D., Wang, Y., Duan, J., Ammons, W., Curd, J., Matteucci, M.... (2011) Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer. Clinical Cancer Research, 18(3), 758-770. DOI: 10.1158/1078-0432.CCR-11-1980  

Garraway, L., & Janne, P. (2012) Circumventing Cancer Drug Resistance in the Era of Personalized Medicine. Cancer Discovery, 2(3), 214-226. DOI: 10.1158/2159-8290.CD-12-0012  

Doebele, R., Pilling, A., Aisner, D., Kutateladze, T., Le, A., Weickhardt, A., Kondo, K., Linderman, D., Heasley, L., Franklin, W.... (2012) Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer. Clinical Cancer Research, 18(5), 1472-1482. DOI: 10.1158/1078-0432.CCR-11-2906  

Katayama, R., Shaw, A., Khan, T., Mino-Kenudson, M., Solomon, B., Halmos, B., Jessop, N., Wain, J., Yeo, A., Benes, C.... (2012) Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers. Science Translational Medicine, 4(120), 120-120. DOI: 10.1126/scitranslmed.3003316  

Vander Heiden MG, Cantley LC, & Thompson CB. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, N.Y.), 324(5930), 1029-33. PMID: 19460998  

Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB.... (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America, 105(48), 18782-7. PMID: 19033189  

Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H.... (2011) Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature genetics, 43(9), 869-74. PMID: 21804546  

Adam J, Hatipoglu E, O'Flaherty L, Ternette N, Sahgal N, Lockstone H, Baban D, Nye E, Stamp GW, Wolhuter K.... (2011) Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer cell, 20(4), 524-37. PMID: 22014577  

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC.... (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature, 462(7274), 739-44. PMID: 19935646  

Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF.... (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer cell, 18(6), 553-67. PMID: 21130701  

Frese, K., Neesse, A., Cook, N., Bapiro, T., Lolkema, M., Jodrell, D., & Tuveson, D. (2012) nab-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer. Cancer Discovery. DOI: 10.1158/2159-8290.CD-11-0242  

Miyake H, Nelson C, Rennie PS, & Gleave ME. (2000) Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer research, 60(1), 170-6. PMID: 10646870  

Sennino, B., Ishiguro-Oonuma, T., Wei, Y., Naylor, R., Williamson, C., Bhagwandin, V., Tabruyn, S., You, W., Chapman, H., Christensen, J.... (2012) Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors. Cancer Discovery. DOI: 10.1158/2159-8290.CD-11-0240  

Stone, R., Nick, A., McNeish, I., Balkwill, F., Han, H., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G., Pecot, C., Coward, J.... (2012) Paraneoplastic Thrombocytosis in Ovarian Cancer. New England Journal of Medicine, 366(7), 610-618. DOI: 10.1056/NEJMoa1110352  

Coward, J., Kulbe, H., Chakravarty, P., Leader, D., Vassileva, V., Leinster, D., Thompson, R., Schioppa, T., Nemeth, J., Vermeulen, J.... (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. Clinical Cancer Research, 17(18), 6083-6096. DOI: 10.1158/1078-0432.CCR-11-0945  

Tanas, M., Sboner, A., Oliveira, A., Erickson-Johnson, M., Hespelt, J., Hanwright, P., Flanagan, J., Luo, Y., Fenwick, K., Natrajan, R.... (2011) Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma. Science Translational Medicine, 3(98), 98-98. DOI: 10.1126/scitranslmed.3002409  

Hu, R., Dawood, S., Holmes, M., Collins, L., Schnitt, S., Cole, K., Marotti, J., Hankinson, S., Colditz, G., & Tamimi, R. (2011) Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women. Clinical Cancer Research, 17(7), 1867-1874. DOI: 10.1158/1078-0432.CCR-10-2021  

Clegg, N., Wongvipat, J., Tran, C., Ouk, S., Dilhas, A., Joseph, J., Chen, Y., Grillot, K., Bischoff, E., Cai, L.... (2012) ARN-509: a novel anti-androgen for prostate cancer treatment. Cancer Research. DOI: 10.1158/0008-5472.CAN-11-3948  

Scher, H. (2005) Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis. Journal of Clinical Oncology, 23(32), 8253-8261. DOI: 10.1200/JCO.2005.03.4777  

Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, & Sawyers CL. (2004) Molecular determinants of resistance to antiandrogen therapy. Nature medicine, 10(1), 33-9. PMID: 14702632  

Carver, B., Chapinski, C., Wongvipat, J., Hieronymus, H., Chen, Y., Chandarlapaty, S., Arora, V., Le, C., Koutcher, J., Scher, H.... (2011) Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer. Cancer Cell, 19(5), 575-586. DOI: 10.1016/j.ccr.2011.04.008  

Ling, J., Kang, Y., Zhao, R., Xia, Q., Lee, D., Chang, Z., Li, J., Peng, B., Fleming, J., Wang, H.... (2012) KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 21(1), 105-120. DOI: 10.1016/j.ccr.2011.12.006  

Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R., Bardelli, A., & Bernards, R. (2012) Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. DOI: 10.1038/nature10868  

O'Hagan, H., Wang, W., Sen, S., DeStefano Shields, C., Lee, S., Zhang, Y., Clements, E., Cai, Y., Van Neste, L., Easwaran, H.... (2011) Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands. Cancer Cell, 20(5), 606-619. DOI: 10.1016/j.ccr.2011.09.012  

Federico A, Morgillo F, Tuccillo C, Ciardiello F, & Loguercio C. (2007) Chronic inflammation and oxidative stress in human carcinogenesis. International journal of cancer. Journal international du cancer, 121(11), 2381-6. PMID: 17893868  

Xia, D., Wang, D., Kim, S., Katoh, H., & DuBois, R. (2012) Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nature Medicine. DOI: 10.1038/nm.2608  

Wang, D., & DuBois, R. (2009) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29(6), 781-788. DOI: 10.1038/onc.2009.421  

Xia, D., Wang, D., Kim, S., Katoh, H., & DuBois, R. (2012) Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nature Medicine. DOI: 10.1038/nm.2608  

Schrauder, M., Strick, R., Schulz-Wendtland, R., Strissel, P., Kahmann, L., Loehberg, C., Lux, M., Jud, S., Hartmann, A., Hein, A.... (2012) Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection. PLoS ONE, 7(1). DOI: 10.1371/journal.pone.0029770  

Lee, R., Feinbaum, R., & Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5), 843-854. DOI: 10.1016/0092-8674(93)90529-Y  

Foss KM, Sima C, Ugolini D, Neri M, Allen KE, & Weiss GJ. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 6(3), 482-8. PMID: 21258252  

Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, & Sozzi G. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proceedings of the National Academy of Sciences of the United States of America, 108(9), 3713-8. PMID: 21300873  

Häusler, S., Keller, A., Chandran, P., Ziegler, K., Zipp, K., Heuer, S., Krockenberger, M., Engel, J., Hönig, A., Scheffler, M.... (2010) Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. British Journal of Cancer, 103(5), 693-700. DOI: 10.1038/sj.bjc.6605833